VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference

NEXT STORY
American BriVision Announces Strategic Collaboration with BioLite Japan
PREV STORY
World Point-of-Care Testing Industry Report 2019-2022 – Opportunities Presented by Physical Robotic Telepresence & Smart Virtual Assistant in Association with Mobile Devices
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Epizyme Announces Path Toward Tazemetostat Registration in Epithelioid Sarcoma and Reports New Clinical Data to be Presented at ASCO

Path Toward Submission for Accelerated Approval Tazemetostat Demonstrates Clinically Meaningful Activity in Epithelioid Sarcoma; ...

author_avatar
NASDAQ Market News

Cyclacel Reports Updated Data From Its DNA Damage Response Program on Seliciclib and Sapacitabine Combination in Patients With Solid Tumors at ASCO

BERKELEY HEIGHTS, N.J., June 06, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ...

author_avatar
NASDAQ Market News

MacroGenics Announces Date of Fourth Quarter and Full Year 2016 Financial Results Conference Call

ROCKVILLE, MD, Feb. 16, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News